1/24 Recently, I started reading a lot about vascular waterfall (VW) and its importance in cardiovascular physiology. It seemed confusing at first, but the more I read about it, the more it fascinated me. 🧵 about physiology!

RT @wszczeklik: Wszystko, co mówi poseł Romana Fritz z mównicy sejmowej jest kłamstwem. Najwyraźniej nie przeczytał wytycznych o których ws…

RT @bercik_beagle: how i sleep knowing that oasis is gonna tour again. biblical celestial divine @liamgallagher

@EM_RESUS Is that a myocardial infarction

RT @jesuitnews: Br. Guy Consolmagno, SJ, director of the director of Vatican Observatory: “When we show the universe is rational and beauti…

@nickmmark Hey! Please verify - the mortality difference is not significant in terms of absolute mortality differences (look at absolute difference 95%CIs), they report p value for a test if the difference is less than margin 5.4%. The mortality diff of 1.5% is not stat significant.

@Rippansalhotra @ABCDEcografia @IM_Crit_ @iceman_ex @ross_prager @NephroP Maybe aortic stiffeness is skyrocketing with concurrent severe vasodilation. Idk, maybe this would explain the initial raise in SBP with such a low DBP.... anyways, i would place a second arterial line + manual cuff

RT @IM_Crit_: This is terrible

@ross_prager Is there any evidence to support this? As far as I know these autoregulation curves are really theoretical and get completely unreliable when you treat a patient with vasopressors. Also is there any evidence to support higher pressures in chronically hypertensive pts ?

@DrFDamico @giovannilandoni @alessanro_pruna @DrToddLee 😏😏

@OasisMania @liamgallagher @NoelGallagher D’you know what I mean is just soooo incredibly good… it basically has never been out of my playlist for years now

RT @DrFDamico: Evidence on blood pressure targets in critically ill patients shows that Mean Arterial Pressure is not always equal to end-o…

@drmohansai @Ssuhani_surgeon Please let me know if you know any good quality evidence that short term use (premedication) of short acting BZD (midazolam) in 1-2mg doses is harmful in the elderly

RT @wszczeklik: Dzisiaj prof. Roman Jaeschke otrzymał tytuł doktora honoris causa Uniwersytetu Jagiellońskiego - najważniejsze wyróżnienie…

@DrToddLee @PulmCrit @CHassager Does it suggest problems with randomization?

@PulmCrit @CHassager Important limitations: high chance of complications, no clear early mortality benefit (only at 180 days?), low prior probability of benefit (IABP and ecmo didn’t show improvements in the past), no confirmatory trials

@DrFDamico @giovannilandoni @SRAnesthesiaICU @DrToddLee @GiacomoMonti @MMarmiere @alessanro_pruna @Stefano__Turi @alebelletti1 Very enlightening paper! I especially love the part „the more vasopressors patient needs, the lower MAP we should accept”. Congratulations!

RT @DrFDamico: The C.L.E.A.R. approach of protective hemodynamics in critically ill patients is a step forward in embracing complexity, mov…

@ThinkingCC @StevenMathern Exactly! MAP of 80 achieved by fluids is a different state that MAP of 80 achieved by norepi

RT @AndromedaShock: Our V Hemodynamic Monitoring and Tissue Perfusion Course on Nov 27-29 is the most comprehensive forum to discuss all th…

Many thanks to @AndromedaShock @edu_kattan and @wszczeklik for helping with the study!!!